Managing anovulatory infertility and polycystic ovary syndrome  

Oleh:

Balen, Adam H. ; Rutherford, Anthony J.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: British Medical Journal (keterangan: ada di Proquest) vol. 335 no. 7621 (Sep. 2007), page 663.

Ketersediaan

Perpustakaan FK Nomor Panggil: B16.K.2007.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

In this second overview of the current management of infertility we discuss anovulatory infertility and polycystic ovary syndrome. This syndrome (formerly known as Stein-Leventhal syndrome) is the most common hormonal disturbance in women—around one fifth of women in the United Kingdom are affected. It is also the most common reason for women not to ovulate, and the combination of being overweight and having polycystic ovary syndrome can have a profound effect on reproductive health. Summary points Polycystic ovary syndrome is the most common endocrine problem affecting women and the most common cause of anovulatory infertility Oral clomifene citrate remains the first line treatment to induce ovulation Gonadotrophin treatment needs careful monitoring to reduce risk of multiple pregnancy Despite early promise, the role of metformin and insulin lowering agents is unclear in the management of anovulatory polycystic ovary syndrome Sources and selection criteria We referred to the Cochrane database of systematic reviews, The National Institute for Health . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali